Functional activation of cerebral blood flow abolished by scopolamine is reversed by cognitive enhancers associated with cholinesterase inhibition: A positron emission tomography study in unanesthetized monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 3, 1997, Pages 1408-1414

  Tsukada, Hideo ^a,b   Kakiuchi, Takeharu ^a   Ando, Ichiro ^a   Ouchi, Yasuomi ^c  

^a CENTRAL RESEARCH LABORATORY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c HAMAMATSU MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; KETAMINE; PHYSOSTIGMINE; SCOPOLAMINE; TACRINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD FLOW; CHOLINERGIC NERVE CELL; COGNITION; CONTROLLED STUDY; DEMENTIA; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY; SOMATOSENSORY STIMULATION; TACTILE STIMULATION; VIBRATION SENSE;

ANIMALS; BRAIN; CEREBROVASCULAR CIRCULATION; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; INDANS; MACACA MULATTA; MALE; PHYSOSTIGMINE; PIPERIDINES; SCOPOLAMINE; TACRINE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030957933     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. ADEM, A., JOSSAN, S. S. AND ORELAND, L.: Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase. Neurosci. Lett. 107: 313-317, 1989.
2. BASSANT, M. H., JAZAT, F. AND LAMOUR, Y.: Tetrahydroaminoacridine and physostigmine increase cerebral glucose utilization in specific cortical and subcortical regions in the rat. J. Cereb. Blood Flow Metab. 13: 855-864, 1993.
3. BASSANT, M. H., JAZAT-POINDESSOUS, F. AND LAMOUR, Y.: Metabolic response to tacrine (THA) and physostigmine in the aged rat brain. J. Cereb. Blood Flow Metab. 15: 1093-1102, 1995.
4. BLIN, J., RAY, C. A., PIERCEY, M. F., BARTKO, J. J., MOURADIAN, M. M. AND CHASER, T. N.: Comparison of cholinergic drug effects on regional brain glucose consumption in rats and humans by means of autoradiography and positron emission tomography. Brain Res. 635: 196-202, 1995.
5. CROSBY, G., CRANE, A. M., JEHLE, J. AND SOKOLOFF, L.: The local metabolic effects of somatosensory stimulation in the central nervous system of rats given pentobarbital or nitrous oxide. Anesthesiology 58: 38-43, 1983.
6. DAVIS, K. L. AND MOHS, R. C.: Enhancement of memory process in Alzheimer's disease with multiple-dose intravenous physostigmine. Am. J. Psychiatry 139: 1421-1424, 1982.
7. DRUKARCH, B., LEYSEN, J. E. AND STOOF, J.: Further analysis of the neuropharmacological profile of 9-amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease. Life Sci. 42: 1011-1017, 1988.
8. 15O tissue activity. J. Nucl. Med. 30: 141-149, 1989.
9. FOX, P. T.. MINTUN, M. A., REIMAN, E. M. AND RAICHLE, M. E.: Enhanced detection of focal brain responses using intersubject averaging and changedistribution analysis of subtracted PET images. J. Cereb. Blood Flow Metab. 8: 642-653, 1988a.
10. FOX, P. T. AND RAICHLE, M. E.: Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc. Natl. Acad. Sci. U.S.A. 83: 1140-1144, 1986.
11. FOX, P. T., RAICHLE, M. E., MINTUN, M. A. AND DENCE, C.: Nonoxidative glucose consumption during focal physiological neural activity. Science (Wash. DC) 241: 462-464, 1988b.
12. FREEMAN, S. E. AND DAWSON, R. M.: Tacrine: A pharmacological review. Prog. Neurobiol. 36: 257-277, 1991.
13. FRISTON, K. J., FRITH, C. D., LIDDLE, P. F., DOLAN, R. J., LAMMERTSMA, A. A. AND FRACKWIAK, R. S. J.: The relationship between global and local changes in PET scans. J. Cereb. Blood Flow Metab. 10: 458-466, 1990.
14. FUKUYAMA, H., OUCHI, Y., MATSUZAKI, S., OGAWA, M., YAMAUCHI, H., NAGAHAMA, Y., KIMURA, J., YONEKURA, Y. AND TSUKADA, H.: Focal cortical CBF activation is regulated by cortical intrinsic cholinergic neurons. Neurolmage 3: 195-201, 1996.
15. GJEDDE, A., HANSEN, A. J. AND SIKMKOWICZ, E.: Rapid stimulation determination of regional cerebral blood flow and blood-brain glucose transfer in rats. In Cerebral Metabolism and Neural Function, ed. by J. V. Passonneau, pp. 151-160, Williams & Wilkins, London, 1980.
16. HONER, W. G., PROHOVNIK, L. SMITH, G. AND JARVIS, L.: Cortical effects of scopolamine compared to Alzheimer's disease. J. Cereb. Blood Flow Metab. 7: suppl. 1, S387, 1987.
17. 14C). J. Labelled Compd. Radiopharm. 27: 835-839, 1989.
18. KIYOSAWA, M., BARON, J. C., HAMEL, E., PAPPATA, S., DUVERGER, D., RICHE, D., MAZOYER, B., NAQUET, R. AND MACKENZIE, E. T.: Time course of effects of unilateral lesions of the nucleus basalis of Meynert on glucose utilization by the cerebral cortex. Brain 112: 435-455, 1989.
19. 11C-raclopride against anesthetics in rhesus monkey brain. J. Neural Transm. 100: 147-151, 1995.
20. KUROSAWA, M., SATO, A. AND SATO, Y.: Stimulation of the nucleus basalis of Meynert increases acetylcholine release in the cerebral cortex in rats. Neurosci. Lett, 98: 45-50, 1989.
21. LINDAUER, U., VILLRINGEH, A. AND DIRNAGLE, U.: Characterization of CBF response to somatosensory stimulation: Model and influence of anesthetics. Am. J. Physiol. 264: H1223-H1228, 1993.
22. MATSUNO, K., MATSUNAGA, K., SENDA, T. AND MITA, S.: Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex. J. Pharmacol. Exp. Ther. 265: 851-859, 1993.
23. NILSSON, L., ADEM, A., HARDY, J., WINBLAD, B. AND NORDBERG, A.: Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brain via nicotinic receptors? J. Neural. Transm. 70: 357-368, 1987.
24. NORDBERG, A., LILYA, A., LUNDQVIST, H., HARTVIG, P., AMBERLA, K., VIITANEN, M., WARPMAN, U., JOHANSSON, M., HELLSTROM-LINDAHL, E., BJURLING, P., FASTH, K. J., LANGSTRÖM, B. AND WINBLAD, B.: Tacrine restores cholinergic nicotinic receptors and glucose metabolism in Alzheimer patients as visualized by positron emission tomography. Neurobiol. Aging 13: 747-758, 1992.
25. OGAWA, M., MAGATA, Y., OUCHI, Y., FUKUYAMA, H., YAMAUCHI, H., KIMURA, J., YONEKURA, Y. AND KONISHI, J.: Scopolamine abolishes cerebral blood flow response to somatosensory stimulation in anesthetized cats: PET study. Brain Res. 650: 249-252, 1994.
26. 11C-methylspiperone binding in vivo: Positron emission tomography study using conscious rhesus monkey. Brain Res. 663: 191-198, 1994.
27. OUCHI, M., FUKUYAMA, H., OGAWA, M., YAMAUCHI, H., KIMURA, J., MAGATA, Y., YONEKURA, Y. AND KONISHI, J.: Cholinergic projection from the basal forebrain and cerebral glucose metabolism in rats: A dynamic PET study. J. Cereb. Blood Flow Metab. 16: 34-41, 1996.
28. ROGAWPKI, M. A.: Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. Eur. J. Pharmacol. 142: 169-172, 1987.
29. ROLAND, P. E.: Brain Activation, Wiley-Liss, New York, 1993.
30. SATO, A. AND SATO, Y.: Regulation of regional cerebral blood flow by cholinergic fibers originating in the basal forebrain. Neurosci. Res. 14: 242-274, 1992.
31. SCREMIN, O. U., SONNENCHEIN, R. R. AND RUBINSTEIN, E. H.: Cholinergic cerebral vasodilatation in the rabbit: Absence of concomitant metabolic activation J. Cereb. Blood Flow Metab. 2: 241-247, 1982.
32. SHAW, K. P., ARACAVE, Y., AKAIKE, A., DALY, J. W., RICKETT, D. L. AND ALBUQUERQUE, E. X.: The reversible cholinesterase inhibitor physostigmine has channel-blocking and agonist effects on the acetylcholine receptor-ion channel complex. Mol. Pharmacol. 28: 527-538, 1985.
33. SHIMOSEGAWA, E., KANNO, I., HATAZAWA, J., FUJITA, H., IIDA, H., MIURA, S., MURAKAMI, M., INUGAMI, A., OGAWA, T., ITOH, H., OKUDERA, T. AND UEMURA, K.: Photic stimulation study of changing the arterial partial pressure level of carbon dioxide. J. Cereb. Blood Flow Metab. 15: 111-114, 1995.
34. SITARAM, N., WEINGARTNER, H. AND GILLIN, J. C.: Human serial learning: Enhancement with arecoline and choline and impairment with scopolamine. Science (Wash. DC) 201: 274-276, 1978.
35. SOKOLOFF, L.: Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. Ann. Neurol. 22: 2311-2316, 1981.
36. SUGIMOTO, H., IIMURA, Y., YAMANISHI, Y. AND YAMATSU, K.: Synthesis and antiacetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanoni-2-yl]-methylpiperidine hydrochloride (E2020) and related compounds. Bioorg. Med. Chem. Lett. 8: 871-876, 1992.
37. SUMMERS, W. K., MAJOVSKI, L. V., MARSH, G. M., TACHIKI, K. AND KLING, A.: Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N. Engl. J. Med. 315: 1241-1245, 1986.
38. TAKECHI, H., ONOE, H., IMAMURA, K., ONOE, K., KAKIUCHI, T., NISHIYMIA, S., YOSHIKAWA, E., MORI, S., KOSUGI, T., OKADA., H., TSUKADA, H. AND WATANABE, Y.: Brain activation study by use of positron emission tomography in unanesthetized monkey. Neurosci. Lett. 182: 279-282, 1994.
39. TKUKADA, H., KAKIUCHI, T., ANDO, L, SHIZUNO, H., NAKANISHI, S. AND OUCHI, Y.: Regulation of cerebral blood flow response to somatosensory stimulation through the cholinergic system: A PET study in unanesthetized monkey brain. Brain Res. 749: 10-17, 1997.
40. WATANABE, M., UCHIDA, H., OKADA, H., SHIMIZU, K., SATO, N., YOSHIKAWA, E., OHMURA, T., YAMASHITA, T. AND TANAKA, E.: A high resolution PET for animal studies. IEEE Trans. Nucl. Sci. 11: 577-580, 1992.
41. WILDER, J.: Modern psychophysiology and the law of initial value. Am. J. Psychother. 12: 199-221, 1953.
42. WORSLEY, K. J., EVANS, A. C., MARRETT, S. AND NEELIN, P. A.: A three dimensional statistical analysis for CBF activation studies in human brain. J. Cereb. Blood Flow Metab. 12: 900-918, 1992.
43. YAMANISHI, Y., OGURA, H., KOSASA, T., ARAKI, S., SAWA, Y. AND YAMATSU, K.: Inhibition action of E2020, a novel acetylcholinesterase inhibitor, on cholinesterase: Comparison with other inhibitors. In Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Disease, ed. by T. Nagatsu, A. Fisher and M. Yoshida, et al., vol. 2, pp. 409-413, Plenum Press, New York, 1990.